Get Connected:

Rheumatoid Arthritis
The MD Magazine Rheumatoid Arthritis condition center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.

Latest Headlines

Rheumatoid Arthritis Drug Tofacitinib Can Successfully Treat Eczema
Supposedly “unbeatable” eczema (atopic dermatitis) can be successfully treated using tofacitinib, suggest findings published in the Journal of the American Academy of Dermatology.
Researchers did not find any upregulation in the cytokine interleukin 17 A (IL-17A) in active patients with Behçet’s disease.
Patient with autoimmune diseases, like psoriasis, and infected with herpes zoster – commonly known as shingles – have a 50% higher risk of suffering a stroke.
Researchers report that in patients with rheumatoid arthritis (RA), greater positive mood throughout daily life was linked to less pain and fewer RA-related restrictions, while negative mood was linked to an increase in RA-related restrictions.
In a post-hoc analysis, researchers found that the clinical efficacy of tofacitinib after 6 months of treatment was greater than placebo, and appeared similar regardless of methotrexate dose.
A review of six Phase 3 studies shows that tofacitinib is more effective for rheumatoid arthritis treatment than regimens including placebo and a disease modifying anti-rheumatic drug or methotrexate as monotherapy or in combination therapy.
In patients with active rheumatoid arthritis symtoms that persisted even though they were taking methotrexate, baricitinib (Lilly/Incyte) treatment led to "significant improvements" researchers reported at the American College of Rheumatology Annual Meeting in San Francisco, CA.

Most Popular

$vacMongoViewPlus$ $vAR$